Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine



   acyl-coa dehydrogenase, short-chain, deficiency of
  

Disease ID 1992
Disease acyl-coa dehydrogenase, short-chain, deficiency of
Definition
A genetic disorder characterized by deficiency of the enzyme short-chain acyl-coenzyme A dehydrogenase that metabolizes short-chain fatty acids. Signs and symptoms appear in infancy or childhood and may be triggered during fasting or illness. They include vomiting, hypoglycemia, lethargy, hypotonia and failure to thrive.
Synonym
acads deficiency
acadsd
acyl-coa dehydrogenase, short-chain deficiency
butyryl-coa dehydrogenase deficiency
deficiency of butyryl dehydrogenase
deficiency of butyryl-coa dehydrogenase
deficiency of butyryl-coa dehydrogenase (disorder)
deficiency of unsaturated acyl-coa reductase
lipid-storage myopathy secondary to short-chain acyl-coa dehydrogenase deficiency
scad
scad - short chain acyl-coa dehydrogenase deficiency
scad deficiency
scadh deficiency
short chain acyl coa dehydrogenase deficiency
short chain acyl coa dehydrogenase deficiency (scad)
short chain acyl-coa dehydrogenase deficiency
short-chain acyl-coa dehydrogenase deficiency
short-chain acyl-coa dehydrogenase deficiency (scad)
short-chain acyl-coenzyme a dehydrogenase deficiency
short-chain acyl-coenzyme a dehydrogenase deficiency (scad)
Orphanet
OMIM
ICD10
UMLS
C0342783
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:12)
C0009319  |  colitis  |  9
C0027051  |  myocardial infarction  |  3
C0027051  |  myocardial infarct  |  3
C0016052  |  fibromuscular dysplasia  |  2
C0409974  |  lupus erythematosus  |  1
C0024796  |  marfan's syndrome  |  1
C0010068  |  coronary artery disease  |  1
C0020538  |  hypertension  |  1
C0155626  |  acute mi  |  1
C0024141  |  systemic lupus erythematosus  |  1
C0009782  |  connective tissue disorder  |  1
C0009782  |  connective tissue disorders  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:1)
35  |  ACADS  |  CLINVAR;CTD_human;OMIM;ORPHANET;UNIPROT
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:2)
34  |  ACADM  |  CIPHER
35  |  ACADS  |  CTD_human
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:14)
34  |  ACADM  |  3.247  |  DISEASES
36  |  ACADSB  |  4.109  |  DISEASES
37  |  ACADVL  |  2.766  |  DISEASES
205  |  AK4  |  2.145  |  DISEASES
875  |  CBS  |  1.748  |  DISEASES
1376  |  CPT2  |  1.218  |  DISEASES
2108  |  ETFA  |  3.147  |  DISEASES
3030  |  HADHA  |  2.323  |  DISEASES
3155  |  HMGCL  |  3.403  |  DISEASES
5053  |  PAH  |  2.352  |  DISEASES
1468  |  SLC25A10  |  4.487  |  DISEASES
10165  |  SLC25A13  |  3.609  |  DISEASES
29110  |  TBK1  |  2.515  |  DISEASES
23038  |  WDTC1  |  1.848  |  DISEASES
Locus(Waiting for update.)
Disease ID 1992
Disease acyl-coa dehydrogenase, short-chain, deficiency of
Integrated Phenotype
HPO | Name(Total Integrated Phenotypes:17)
HP:0000750  |  Late-onset speech development
HP:0001252  |  Hypotonia
HP:0001250  |  Seizures
HP:0000544  |  CPEO
HP:0003198  |  Myopathic changes
HP:0002500  |  Leukoaraiosis
HP:0001371  |  Flexion contractures of joints
HP:0001263  |  Developmental retardation
HP:0003219  |  Ethylmalonic aciduria
HP:0001254  |  Lethargy
HP:0002650  |  Scoliosis
HP:0000709  |  Psychosis
HP:0001508  |  Weight faltering
HP:0004911  |  Episodic metabolic acidosis
HP:0010628  |  Facial palsy, unilateral or bilateral
HP:0001638  |  Cardiomyopathy
HP:0008872  |  Feeding difficulties in infancy
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:11)
Disease ID 1992
Disease acyl-coa dehydrogenase, short-chain, deficiency of
Manually Symptom(Waiting for update.)
Text Mined Symptom(Waiting for update.)
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
Text Mining Genotype(Total Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:23)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs121908003NA35ACADSumls:C0342783CLINVARNA0.562714419NAACADS12120727115CT
rs121908004NA35ACADSumls:C0342783CLINVARNA0.562714419NAACADS12120737049GT
rs121908005NA35ACADSumls:C0342783CLINVARNA0.562714419NAACADS12120737043GA
rs121908006NA35ACADSumls:C0342783CLINVARNA0.562714419NAACADS12120738859CT
rs147442301NA35ACADSumls:C0342783CLINVARNA0.562714419NAACADS12120727143CT
rs1799958NA35ACADSumls:C0342783CLINVARNA0.562714419NAACADS12120738280GA
rs1800556NA35ACADSumls:C0342783CLINVARNA0.562714419NAACADS12120737875CT
rs28940872949941435ACADSumls:C0342783UNIPROTExpression of the variant R147W SCAD protein, encoded by the 511T-625G allele, in COS-7 cells showed 45% activity at 37 degrees C in comparison with the wild-type protein, comparable levels of activity at 26 degrees C, and 13% activity when incubated at 41 degrees C. This temperature profile is different from that observed for the variant G185S SCAD protein, encoded by the 511C-625A allele, where higher than normal activity was found at 26 and 37 degrees C, and 58% activity was present at 41 degrees C. These results corroborate the notion that the 511C-625A variant allele is one of the possible underlying causes of ethylmalonic aciduria, and suggest that the 511C-->T mutation represents a second susceptibility variation in the SCAD gene.0.5627144191998ACADS12120739356CT
rs28940872NA35ACADSumls:C0342783CLINVARNA0.562714419NAACADS12120739356CT
rs289408741113448635ACADSumls:C0342783UNIPROTOur findings document that patients carrying these SCAD gene variations may develop clinically relevant SCAD deficiency, and that patients with even mild ethylmalonic aciduria should be tested for these variations.0.5627144192001ACADS12120737939CT
rs28940874NA35ACADSumls:C0342783CLINVARNA0.562714419NAACADS12120737939CT
rs28940875NA35ACADSumls:C0342783CLINVARNA0.562714419NAACADS12120739347CG,T
rs289408751113448635ACADSumls:C0342783UNIPROTOur findings document that patients carrying these SCAD gene variations may develop clinically relevant SCAD deficiency, and that patients with even mild ethylmalonic aciduria should be tested for these variations.0.5627144192001ACADS12120739347CG,T
rs28941773NA35ACADSumls:C0342783CLINVARNA0.562714419NAACADS12120739168CT
rs289417731113448635ACADSumls:C0342783UNIPROTOur findings document that patients carrying these SCAD gene variations may develop clinically relevant SCAD deficiency, and that patients with even mild ethylmalonic aciduria should be tested for these variations.0.5627144192001ACADS12120739168CT
rs387906308NA35ACADSumls:C0342783CLINVARNA0.562714419NAACADS12120737085GAG-
rs387906950NA35ACADSumls:C0342783CLINVARNA0.562714419NAACADS12120739141AG
rs387906951NA35ACADSumls:C0342783CLINVARNA0.562714419NAACADS12120737098GA
rs57443665949941435ACADSumls:C0342783UNIPROTExpression of the variant R147W SCAD protein, encoded by the 511T-625G allele, in COS-7 cells showed 45% activity at 37 degrees C in comparison with the wild-type protein, comparable levels of activity at 26 degrees C, and 13% activity when incubated at 41 degrees C. This temperature profile is different from that observed for the variant G185S SCAD protein, encoded by the 511C-625A allele, where higher than normal activity was found at 26 and 37 degrees C, and 58% activity was present at 41 degrees C. These results corroborate the notion that the 511C-625A variant allele is one of the possible underlying causes of ethylmalonic aciduria, and suggest that the 511C-->T mutation represents a second susceptibility variation in the SCAD gene.0.5627144191998ACADS12120737893TC,G
rs57443665NA35ACADSumls:C0342783CLINVARNA0.562714419NAACADS12120737893TC,G
rs61732144NA35ACADSumls:C0342783CLINVARNA0.562714419NAACADS12120737094CT
rs752677472NA35ACADSumls:C0342783CLINVARNA0.562714419NAACADS12120737404CG,T
rs786204691NA35ACADSumls:C0342783CLINVARNA0.562714419NAACADS12120738337GA-
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)
Mapped by lexical matching(Total Items:7)
HP ID HP Name MP ID MP Name Annotation
HP:0003219Ethylmalonic aciduriaMP:0010028aciduriaexcretion of an acid urine
HP:0002500Abnormality of the cerebral white matterMP:0012129failure of blastocyst formationinability to form a blastocyst from a solid ball of cells known as a morula
HP:0008872Feeding difficulties in infancyMP:0011075abnormal macrophage activation involved in immune responseanomaly in the process in which a change in response and behavior of a macrophage results from exposure to a cytokine, chemokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response
HP:0001508Failure to thriveMP:0013294prenatal lethality prior to heart atrial septationdeath prior to the completion of heart atrial septation (Mus: E14.5-15.5)
HP:0001263Global developmental delayMP:0002084abnormal developmental patterningabnormal systematic arrangement of the developing body along an axis
HP:0001252Muscular hypotoniaMP:0004144hypotoniadecreased muscle tension resulting in limpness of the muscles in the resting state, not to be confused with weakness
HP:0000750Delayed speech and language developmentMP:0012251abnormal diaphragm developmentmalformation or incomplete differentiation of the thin musculomembranous barrier separating the abdominal and thoracic cavities and functioning in respiration
Mapped by homologous gene(Total Items:17)
HP ID HP Name MP ID MP Name Annotation
HP:0001252Muscular hypotoniaMP:3000003abnormal Ebner's gland morphologyany structural anomaly of the serous salivary glands which reside adjacent to the moats surrounding the circumvallate and foliate papillae just anterior to the posterior third of the tongue, anterior to the terminal sulcus; these exocrine glands secrete l
HP:0002650ScoliosisMP:0020309increased creatine kinase activityincreased ability of to catalyze the reaction: ATP + creatine = N-phosphocreatine + ADP + 2 H(+).
HP:0000544External ophthalmoplegiaMP:0020214susceptible to malignant hyperthermiaincreased susceptibility to hyperthermia triggered by exposure to certain drugs used for general anesthesia, specifically the volatile anesthetic agents and the neuromuscular blocking agent, succinylcholine
HP:0003198MyopathyMP:0020280increased creatine kinase levelincreased level of the enzyme that catalyzes the reversible transfer of creatine to phosphocreatine
HP:0001263Global developmental delayMP:3000003abnormal Ebner's gland morphologyany structural anomaly of the serous salivary glands which reside adjacent to the moats surrounding the circumvallate and foliate papillae just anterior to the posterior third of the tongue, anterior to the terminal sulcus; these exocrine glands secrete l
HP:0003219Ethylmalonic aciduriaMP:0013659abnormal erythroid lineage cell morphologyany structural anomaly of an immature or mature cell in the lineage leading to and including erythrocytes
HP:0001508Failure to thriveMP:0020234decreased basal metabolismdecrease in heat production of an organism at the lowest level of cell chemistry in an inactive, awake, and fasting state
HP:0010628Facial palsyMP:0020240increased skeletal muscle cell apoptosisincrease in the number of skeletal muscle cells undergoing programmed cell death
HP:0000750Delayed speech and language developmentMP:0020309increased creatine kinase activityincreased ability of to catalyze the reaction: ATP + creatine = N-phosphocreatine + ADP + 2 H(+).
HP:0000709PsychosisMP:0020329decreased capillary densityreduction in the number of capillaries in a given cross-sectional area of a tissue
HP:0001250SeizuresMP:3000003abnormal Ebner's gland morphologyany structural anomaly of the serous salivary glands which reside adjacent to the moats surrounding the circumvallate and foliate papillae just anterior to the posterior third of the tongue, anterior to the terminal sulcus; these exocrine glands secrete l
HP:0001254LethargyMP:0020137decreased bone mineralizationdecrease in the rate at which minerals are deposited into bone
HP:0001638CardiomyopathyMP:0020309increased creatine kinase activityincreased ability of to catalyze the reaction: ATP + creatine = N-phosphocreatine + ADP + 2 H(+).
HP:0002500Abnormality of the cerebral white matterMP:0020137decreased bone mineralizationdecrease in the rate at which minerals are deposited into bone
HP:0008872Feeding difficulties in infancyMP:0020214susceptible to malignant hyperthermiaincreased susceptibility to hyperthermia triggered by exposure to certain drugs used for general anesthesia, specifically the volatile anesthetic agents and the neuromuscular blocking agent, succinylcholine
HP:0001371Flexion contractureMP:0020309increased creatine kinase activityincreased ability of to catalyze the reaction: ATP + creatine = N-phosphocreatine + ADP + 2 H(+).
HP:0004911Episodic metabolic acidosisMP:0011632dilated mitochondriathe luminal space of the mitochondria is increased in volume or area, usually with an increase of contained fluid
Disease ID 1992
Disease acyl-coa dehydrogenase, short-chain, deficiency of
Case(Waiting for update.)